Search results for "52"

showing 10 items of 1043 documents

Immunosenescence and Cytomegalovirus

2010

Since Looney at al. published their seminal paper a decade ago [1] it has become clear that many of the differences in T cell immunological parameters observed between young and old people are related to the age-associated increasing prevalence of infection with the persistent β-herpesvirus HHV-5 (Cytomegalovirus). Ten years later, studies suggest that hallmark age-associated changes in peripheral blood T cell subset distribution may not occur at all in people who are not infected with this virus [[2]; Derhovanessian et al., in press]. Whether the observed changes are actually caused by CMV is an open question, but very similar, rapid changes observed in uninfected patients receiving CMV-in…

lcsh:Immunologic diseases. AllergyAgingCMV ImmunosenescenceageingT cellImmunologyCongenital cytomegalovirus infectionYellow fever vaccine32 Biomedical and Clinical Scienceslcsh:GeriatricsVirusImmune systemMedicine3202 Clinical Sciencesbiologybusiness.industryvirus diseasesImmunosenescenceBiological Sciencesmedicine.disease3204 Immunologylcsh:RC952-954.6Ageingmedicine.anatomical_structureImmunologyT cell subsetQR180biology.proteinCommentaryAntibodylcsh:RC581-607businessmedicine.drugImmunity & ageing
researchProduct

Immunosenescence and lymphomagenesis

2018

Abstract One of the most important determinants of aging-related changes is a complex biological process emerged recently and called “immunosenescence”. Immunosenescence refers to the inability of an aging immune system to produce an appropriate and effective response to challenge. This immune dysregulation may manifest as increased susceptibility to infection, cancer, autoimmune disease, and vaccine failure. At present, the relationship between immunosenescence and lymphoma in elderly patients is not defined in a satisfactory way. This review presents a brief overview of the interplay between aging, cancer and lymphoma, and the key topic of immunosenescence is addressed in the context of t…

lcsh:Immunologic diseases. AllergyAgingLymphomaImmunosenescenceImmunologyContext (language use)Diseaselcsh:Geriatricsmedicine.disease_cause03 medical and health sciences0302 clinical medicineImmune systemimmune system diseaseshemic and lymphatic diseasesmedicineCancerAutoimmune diseasebusiness.industryImmunosenescenceImmune dysregulationmedicine.diseaseLymphomagenesisEpstein–Barr virusLymphomaLymphomagenesiAgeinglcsh:RC952-954.6030220 oncology & carcinogenesisImmunologylcsh:RC581-607business030215 immunologyImmunity & Ageing
researchProduct

Mung Bean nuclease mapping of RNAs 3' end

2009

Abstract A method is described that allows an accurate mapping of 3' ends of RNAs. In this method a labeled DNA probe, containing the presumed 3' end of the RNA under analysis is allowed to anneals to the RNA itself. Mung-bean nuclease is then used to digest single strands of both RNA and DNA. Electrophoretic fractionation of "protected" undigested, labeled DNA is than performed using a sequence reaction of a known DNA as length marker. This procedure was applied to the analysis of both a polyA RNA (Interleukin 10 mRNA) and non polyA RNAs (sea urchin 18S and 26S rRNAs). This method might be potentially relevant for the evaluation of the role of posttrascriptional control of IL-10 in the pat…

lcsh:Immunologic diseases. AllergyAgingNucleaseMung Bean nucleaseHybridization probeImmunologyShort ReportRNANuclease protection assayBiologylcsh:GeriatricsBioinformaticsNon-coding RNAAgeingchemistry.chemical_compoundlcsh:RC952-954.6BiochemistrychemistryelectrophoresisMung Bean Nucleasebiology.proteinRNASmall nucleolar RNAlcsh:RC581-607DNAImmunity & Ageing
researchProduct

Curcumin, inflammation, ageing and age-related diseases

2010

Abstract A Symposium regarding the Pathophysiology of Successful and Unsuccessful Ageing was held in Palermo, Italy between April 7 and 8th 2009. Here the lecture by Sikora with some input from the chairpersons Scapagnini and Barbagallo is summarized. Ageing is manifested by the decreasing health status and increasing probability to acquire age-related disease such as cancer, Alzheimer's disease, atherosclerosis, metabolic disorders and others. They are likely caused by low grade inflammation driven by oxygen stress and manifested by the increased level of pro-inflammatory cytokines such as IL-1, IL-6 and TNF-α, encoded by genes activated by the transcription factor NF-κB. It is believed th…

lcsh:Immunologic diseases. AllergyAgingSettore MED/09 - Medicina InternaImmunologyInflammationClinical nutritionDiseaseReviewlcsh:Geriatricschemistry.chemical_compoundAge relatedMedicinebusiness.industryCancermedicine.diseasePathophysiologylcsh:RC952-954.6AgeingchemistryAgeingImmunologyCURCUMIN AGEING SUCCESSFUL AGINGCurcuminmedicine.symptomlcsh:RC581-607business
researchProduct

Age and immunity

2006

Abstract Longitudinal studies are defining progressive alterations to the immune system associated with increased mortality in the very elderly. Many of these changes are exacerbated by or even caused by chronic T cell stimulation by persistent antigen, particularly from Cytomegalovirus. The composition of T cell subsets, their functional integrity and representation in the repertoire are all markedly influenced by age and by CMV. How these findings relate to epidemiological, functional, genetic, genomic and proteomic studies of human T cell immunosenescence was the subject of intense debate at an international conference held just before Christmas 2005 in the Black Forest.

lcsh:Immunologic diseases. AllergyAgingbiologyT cellRepertoireImmunologyShort ReportCongenital cytomegalovirus infectionImmunosenescencelcsh:Geriatricsmedicine.diseaseaged aging apoptosis article CD4+ CD25+ T lymphocytelcsh:RC952-954.6Immune systemmedicine.anatomical_structureAntigenImmunityImmunologybiology.proteinmedicineAntibodylcsh:RC581-607
researchProduct

Role of persistent CMV infection in configuring T cell immunity in the elderly

2007

Abstract Ageing is associated with declines in many physiological parameters, including multiple immune system functions. The rate of acceleration of the frequency of death due to cardiovascular disease or cancer seems to increase with age from middle age up to around 80 years, plateauing thereafter. Mortality due to infectious disease, however, does not plateau, but continues to accelerate indefinitely. The elderly commonly possess oligoclonal expansions of T cells, especially of CD8 cells, which, surprisingly, are often associated with cytomegalovirus (CMV) seropositivity. This in turn is associated with many of the same phenotypic and functional alterations to T cell immunity that have b…

lcsh:Immunologic diseases. AllergyAgingbiologybusiness.industryImmunologyMembrane raftReviewDiseaseImmunosenescencelcsh:GeriatricsBioinformaticsVaccinationlcsh:RC952-954.6aged aging antigen expression apoptosis cancer incidence CD4+ T lymphocyte CD8+ T lymphocyte cellular immunityAgeingImmune systemInfectious disease (medical specialty)ImmunityImmunologybiology.proteinMedicineAntibodybusinesslcsh:RC581-607Immunity & Ageing
researchProduct

Hemostasis and ageing

2008

Abstract On March 19, 2008 a Symposium on Pathophysiology of Ageing and Age-Related Diseases was held in Palermo, Italy. The lecture of D. Mari on Hemostasis and ageing is summarized herein. Physiological ageing is associated with increased plasma levels of many proteins of blood coagulation together with fibrinolysis impairment. This may be of great concern in view of the known association between vascular and thromboembolic diseases and ageing. On the other hand, centenarians are characterized by a state of hypercoagulability and possession of several high-risk alleles and well-known atherothrombotic risk markers but this appears to be compatible with longevity and/or health. Parameters c…

lcsh:Immunologic diseases. AllergyAginggene polymorphismmedia_common.quotation_subjectmedicine.medical_treatmentImmunologyShort Reportlcsh:GeriatricsBioinformaticsFibrinolysisSettore MED/05 - Patologia ClinicaMedicinemedia_commonbusiness.industryGeriatrics gerontologyLongevityPlasma levelsHemostasilcsh:RC952-954.6ageingAgeingBiological significanceHemostasisImmunologylcsh:RC581-607businessImmunity & Ageing
researchProduct

INNATE IMMUNITY AND INFLAMMATION IN AGEING: A KEY FOR UNDERSTANDING AGE-RELATED DISEASES.

2005

Abstract The process of maintaining life for the individual is a constant struggle to preserve his/her integrity. This can come at a price when immunity is involved, namely systemic inflammation. Inflammation is not per se a negative phenomenon: it is the response of the immune system to the invasion of viruses or bacteria and other pathogens. During evolution the human organism was set to live 40 or 50 years; today, however, the immune system must remain active for much a longer time. This very long activity leads to a chronic inflammation that slowly but inexorably damages one or several organs: this is a typical phenomenon linked to ageing and it is considered the major risk factor for a…

lcsh:Immunologic diseases. AllergyAgingmedia_common.quotation_subjectLongevityImmunologyInflammationReviewDiseaselcsh:GeriatricsSystemic inflammationImmune systemImmunitymedicinePermissiveCytokinemedia_commonInflammationInnate immune systembusiness.industryLongevityInnate Immunitylcsh:RC952-954.6Immunologymedicine.symptomlcsh:RC581-607businessAge-related diseases
researchProduct

Alzheimer's disease: new diagnostic and therapeutic tools.

2008

Abstract On March 19, 2008 a Symposium on Pathophysiology of Ageing and Age-Related diseases was held in Palermo, Italy. Here, the lectures of M. Racchi on History and future perspectives of Alzheimer Biomarkers and of G. Scapagnini on Cellular Stress Response and Brain Ageing are summarized. Alzheimer's disease (AD) is a heterogeneous and progressive neurodegenerative disease, which in Western society mainly accounts for clinica dementia. AD prevention is an important goal of ongoing research. Two objectives must be accomplished to make prevention feasible: i) individuals at high risk of AD need to be identified before the earliest symptoms become evident, by which time extensive neurodege…

lcsh:Immunologic diseases. AllergyAgingmedicine.medical_specialtyImmunologyShort ReportCellular homeostasisDiseaselcsh:Geriatrics03 medical and health sciences0302 clinical medicineEffective interventionsIntervention (counseling)Cellular stress responsemedicineDementiaIntensive care medicine030304 developmental biologyalzheimer ageing inflammation0303 health sciencesbusiness.industryNeurodegenerationmedicine.disease3. Good healthlcsh:RC952-954.6AgeingAgeingImmunologybusinesslcsh:RC581-607030217 neurology & neurosurgeryImmunityageing : IA
researchProduct

Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case-control study

2008

Abstract Background Nitric oxide (NO) synthesized by endothelial nitric oxide synthase (eNOS) plays an important role in regulation of endothelial function and in the control of blood pressure. However, the results from some studies on the association between three clinically relevant eNOS gene polymorphisms (G894T, T786C and intron 4b/a) and essential hypertension are unclear. We designed a case-control study to evaluate the influence of eNOS polymorphisms on target organ damage in 127 hypertensives and 67 normotensives. Clinical evaluation, biochemical parameters, Urinary Albumin Excretion (UAE) and echocardiogram were performed to characterize target organ damage. eNOS polymorphism were …

lcsh:Immunologic diseases. AllergyAgingmedicine.medical_specialtyPopulationImmunologyClinical nutritionlcsh:GeriatricsBioinformaticsEssential hypertensionNitric oxidechemistry.chemical_compoundEnosInternal medicinemedicineeducationeducation.field_of_studybiologybusiness.industryResearchCase-control studybiology.organism_classificationmedicine.diseaseAgeinglcsh:RC952-954.6Blood pressureEndocrinologychemistrybusinesslcsh:RC581-607Body mass indexImmunity & ageing : I & A
researchProduct